Ali Sadoughi, MD
Pulmonary Disease · Saint Louis, MONPI 1699933879
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Olympus America Inc. at 36.7% of the total. Reporting peaked in 2024 at $36,911 and has fallen 55.7% since, to $16,336 in 2025. Among pulmonary disease clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 148 payments — averaging $590.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus America Inc.$32K
- Merit Medical Systems Inc$23K
- Intuitive Surgical$9K
- Olympus Medical Systems Corporation$7K
- Veran Medical Technologies, Inc.$6K
- Siemens Medical Solutions USA, Inc.$2K
- plus $8K from 17 others
Across 1 payment — averaging $3750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gyrus ACMI, Inc.$4K
What the payments were for
- Consulting fees$40,22646%
- Speaking & faculty fees$26,05830%
- Travel & lodging$9,73611%
- Food & beverage$3,4484%
- Education$7,6259%
- Gifts$3010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus America Inc. | 44 | $32,115 |
| Merit Medical Systems Inc | 21 | $23,438 |
| Intuitive Surgical | 20 | $9,240 |
| Olympus Medical Systems Corporation | 7 | $7,028 |
| Veran Medical Technologies, Inc. | 4 | $6,351 |
| Siemens Medical Solutions USA, Inc. | 4 | $1,591 |
| Boston Scientific | 7 | $1,220 |
| Olympus Corporation | 3 | $1,176 |
| Gyrus ACMI, Inc. | 3 | $1,166 |
| Mauna Kea Technologies, Inc. | 1 | $900 |
| Olympus Corporation Of The Americas | 11 | $648 |
| Ambu Inc. | 2 | $517 |
| Steris Corporation | 3 | $455 |
| Spiration, Inc. | 1 | $365 |
| Serpex Medical Inc | 1 | $231 |
| Noah Medical Corporation | 4 | $228 |
| BD | 2 | $164 |
| Galvanize Therapeutics, Inc | 2 | $139 |
| Johnson & Johnson | 2 | $126 |
| ANI Pharmaceuticals, Inc. | 1 | $125 |
| Sanofi | 2 | $71 |
| Pinnacle Biologics, Inc | 1 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVIS EXERA III BRONCHOVIDEOSCOPE$11,033
- Olympus Bronchoscopes$10,799
- SPiN Vision Video Processor$6,380
- Da Vinci Surgical System$6,099
- AERO Stent and Delivery System$5,484
- EVES EUS ULTRASOUND BRONCHOFIBERVIDEOSCOPE$5,240
- ION$3,000
- Aspira$1,500
- Olympus Capital Accessories$501
- Olympus Respiratory Accessories$501
- Artis icono floor$398
- TRUFREEZE$366
- PURIFIED CORTROPHIN GEL$125
- Cios Spin$117
- Monarch Platform$106
- ALIYA SYSTEM$104
How this compares
$87,393 in reported general payments places this provider in the 90th percentile of 295 pulmonary disease providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $35,176 |
| Breo ElliptaFluticasone/Vilanterol | 69 | $26,958 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 475 | $15,151 |
| Atrovent HfaIpratropium Bromide | 22 | $12,092 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 24 | $10,737 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 45 | $7,910 |
| Incruse ElliptaUmeclidinium Bromide | 14 | $4,674 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $2,982 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 14 | $2,736 |
| Fluticasone Propionate | 18 | $251 |
| Montelukast Sodium | 14 | $72 |
| Prednisone | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Saint Louis
- Derek ByersSaint Louis$835K
- Alexander ChenSaint Louis$679K
- Joseph OjileSaint Louis$538K
- Edward CharbekSaint Louis$372K
- Marin KollefSaint Louis$264K
- Praveen ChennaSaint Louis$255K
- Murali ChakinalaSaint Louis$172K
- Janet LeeSaint Louis$143K
- Ramsey HachemSaint Louis$79K
- Shiraz DaudSaint Louis$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.